Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
34,58 USD | -1,55% | -2,21% | +36,67% |
Omzet 2024 * | 56,01 mln. 52,49 mln. | Omzet 2025 * | 71,69 mln. 67,17 mln. | Marktkapitalisatie | 2,15 mld. 2,01 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -216 mln. -202 mln. | Nettowinst (verlies) 2025 * | -251 mln. -235 mln. | EV/omzet 2024 * | 29,1 x |
Nettoliquiditeiten 2024 * | 516 mln. 484 mln. | Nettoliquiditeiten 2025 * | 463 mln. 434 mln. | EV/omzet 2025 * | 23,5 x |
K/w-verhouding 2024 * |
-10,9
x | K/w-verhouding 2025 * |
-10
x | Werknemers | 187 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,62% |
Recentste transcriptie over Kymera Therapeutics, Inc.
1 dag | -1,55% | ||
1 week | -2,21% | ||
Lopende maand | -13,45% | ||
1 maand | -12,07% | ||
3 maanden | +26,57% | ||
6 maanden | +192,64% | ||
Lopend jaar | +36,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nello Mainolfi
FOU | Founder | 45 | 01-09-15 |
Bruce Jacobs
DFI | Director of Finance/CFO | 54 | 15-07-19 |
Juliet Williams
CTO | Chief Tech/Sci/R&D Officer | - | 05-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 28/03 |
Joanna Horobin
BRD | Director/Board Member | 69 | 01-05-18 |
John Maraganore
BRD | Director/Board Member | 60 | 17-01-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.10% | 0 M€ | 0,00% | - | |
0.09% | 0 M€ | 0,00% | - | |
0.04% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 34,81 | -0,88% | 92 179 |
18-04-24 | 35,12 | +4,03% | 619 729 |
17-04-24 | 33,76 | -0,50% | 433 665 |
16-04-24 | 33,93 | -1,34% | 492 350 |
15-04-24 | 34,39 | -3,34% | 528 869 |
uitgestelde koers Nasdaq, 19 april 2024 om 16:55 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+36,67% | 2,15 mld. | |
-1,31% | 41,35 mld. | |
+41,93% | 40,38 mld. | |
+3,57% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+2,12% | 24,07 mld. | |
-23,67% | 18,36 mld. | |
-3,31% | 11,68 mld. | |
+21,20% | 11,6 mld. | |
+7,96% | 11,15 mld. |